TTK drug discovery program presented at Protein Kinases conference in Berlin
Guido Zaman and Suzanne van Gerwen will attend the 10th “Protein Kinases in Drug Discovery” conference, that will be held in Berlin on May 7th and 8th.
On Friday, May 8th, Guido Zaman will present on the NTRC’s TTK (Mps1) kinase inhibitor program.
Title of presentation: Selective TTK inhibitors with long target residence time and potent anti-tumor activity
Time: 8:45 a.m.